X-box binding protein 1 (XBP-1) enhances colorectal cancer cell invasion

References

• Giatromanolaki A, Sivridis E, Koukourakis MI. Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol. 2006;29(4):408–17.
   PubMed Web of Science ®Google Scholar
• Compton CC, Greene FL. The staging of colorectal cancer: and beyond. CA. Cancer J Clin. 2004;54(6):295–308.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA. Cancer J Clin. 2007;57(1):43–66.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Mai M, Wilson M, Kitadai Y, Bucana C, Ellis L. Site-dependent expression of vascular endothelial growth factor, angiogenesis and proliferation in human gastric carcinoma. Int J Oncol. 1996;8(4):701–5.
   PubMed Web of Science ®Google Scholar
• Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82(1):4–6.
   PubMed Web of Science ®Google Scholar
• Engstrom PF. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy. Pharmacotherapy. 2008;2(11 Pt 2):18S–22S.
   Google Scholar
• Tsuji A. [Colorectal cancer chemotherapy and anti-EGFR therapy]. Gan To Kagaku Ryoho. 2011;38(6):901–6.
   PubMedGoogle Scholar
• Aranda E, Abad A, Carrato A, Cervantes A, Garcia-Foncillas J, Garcia Alfonso P, et al. Treatment recommendations for metastatic colorectal cancer. Clin Transl Oncol. 2011;13(3):162–78.
   PubMed Web of Science ®Google Scholar
• Fuloria J. Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer. Onco Targets Ther. 2012;5:133–42.
   PubMed Web of Science ®Google Scholar
• Ellgaard L, Riek R, Herrmann T, Guntert P, Braun D, Helenius A, et al. NMR structure of the calreticulin P-domain. Proc Natl Acad Sci USA. 2001;98(6):3133–8.
   PubMed Web of Science ®Google Scholar
• Nawrocki ST, Carew JS, Dunner K Jr, Boise LH, Chiao PJ, Huang P, et al. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res. 2005;65(24):11510–9.
   PubMed Web of Science ®Google Scholar
• Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer. 2004;4(12):966–77.
   PubMed Web of Science ®Google Scholar
• Harding HP, Calfon M, Urano F, Novoa I, Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol. 2002;18:575–99.
   PubMed Web of Science ®Google Scholar
• Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005;74:739–89.
   PubMed Web of Science ®Google Scholar
• Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, et al. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 2002;16(4):452–66.
   PubMed Web of Science ®Google Scholar
• Mhaidat NM, Abdul-Razzak KK, Alkofahi AS, Alsarhan AM, Aldaher AN, Thorne RF. Altholactone induces apoptotic cell death in human colorectal cancer cells. Phytother Res. 2012;26(6):926–31.
   PubMed Web of Science ®Google Scholar
• Mhaidat NM, Zhang XD, Jiang CC, Hersey P. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin Cancer Res. 2007;13(4):1308–14.
   PubMed Web of Science ®Google Scholar
• Landgren E, Schiller P, Cao Y, Claesson-Welsh L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene. 1998;16(3):359–67.
   PubMed Web of Science ®Google Scholar
• Yanagitani K, Imagawa Y, Iwawaki T, Hosoda A, Saito M, Kimata Y, et al. Cotranslational targeting of XBP1 protein to the membrane promotes cytoplasmic splicing of its own mRNA. Mol Cell. 2009;34(2):191–200.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Onda M, Nagai H, Nagahata T, Ogawa K, Emi M. Upregulation and overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast cancers. Breast Cancer. 2003;10(4):301–6.
   PubMedGoogle Scholar
• Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol. 2003;38(5):605–14.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Suzuki S, Inaguma S, Ikeda Y, Cho YM, Nishiyama N, et al. Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers. Prostate. 2002;50(3):154–61.
   PubMed Web of Science ®Google Scholar
• Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;5(Suppl 5):10–17.
   Google Scholar
• Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979;52(620):650–6.
   PubMed Web of Science ®Google Scholar
• Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia. Mol Oncol. 2008;2(1):41–53.
   PubMed Web of Science ®Google Scholar
• Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997;29(5):354–62.
   PubMed Web of Science ®Google Scholar
• Blais JD, Addison CL, Edge R, Falls T, Zhao H, Wary K, et al. PERK-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol. 2006;26(24):9517–32.
   PubMed Web of Science ®Google Scholar
• Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287(5453):664–6.
   PubMed Web of Science ®Google Scholar
• Nagelkerke A, Bussink J, Bertolotti A, Mujcic H, Wouters BG, Lehmann S, Sweep F, Span P. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Res. 2013;15(1):R2. doi: 10.1186/bcr3373.
   PubMed Web of Science ®Google Scholar
• Ghosh R, Lipson KL, Sargent KE, Mercurio AM, Hunt JS, Ron D, Urano F. Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One. 2010;5, e9575.
   PubMed Web of Science ®Google Scholar